Our program was initially started in 2016 with the mission of reimagining how men can be more easily treated for one of the most common disease states in the world affecting men, Benign Prostatic Hyperplasia (BPH). Prodeon Medical, Inc. has developed and is investigating a minimally invasive and patient-friendly approach to treating Lower Urinary Tract Symptoms (LUTS) due to BPH 
The procedure, known as the PURE™ (Prostatic Urethral REshaping) procedure uses the investigational the Urocross™ Expander System and Retrieval Sheath to relieve symptoms associated with BPH.

Caution: The Urocross Expander System and Retrieval Sheath are for investigational use only under the Expander-2 Clinical Trial (NCT: 05400980) and are not for sale in the U.S. or outside the U.S.

Biotechnology

Health Care

Medical Devices

Prodeon Medical, Inc.

Paul M. Edwards

Dan Condon

Jayachandran Ravichandran

Craig Purdy

Kimberly Marquez

Ted McKittrick Acrp-Cp

The Clinical Research Team at Prodeon Medical, Inc. is dedicated to advancing the understanding and effectiveness of the PURE™ procedure for treating Benign Prostatic Hyperplasia (BPH). By conducting clinical trials, analyzing data, and ensuring compliance with regulatory standards, the team plays a crucial role in evaluating the safety and efficacy of the investigational Urocross™ Expander System and Retrieval Sheath, ultimately aiming to enhance patient outcomes and support product development.

Clinical Research Team

Leadership Team

��

Clinical Research Team

About

Team members

Other teams at Prodeon Medical, Inc.

Leadership Team

��������

Clinical Research Team

About

Team members

Other teams at Prodeon Medical, Inc.

Leadership Team

��